Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Axplora’s Chasse-sur-Rhône CDMO Site in France Passes Inspection | Contract Pharma
Breaking News

Axplora’s Chasse-sur-Rhône CDMO Site in France Passes Inspection

Confirms the site’s full compliance with current Good Manufacturing Practices (cGMP).

Axplora’s Chasse-sur-Rhône CDMO site in France has successfully passed its latest on-site inspection by the French National Agency for Medicines and Health Products Safety (ANSM).

Conducted in February 2025, the inspection confirmed the site’s full compliance with current Good Manufacturing Practices (cGMP), with no critical remarks or 483 observations. This achievement marks the ninth successful inspection at Chasse-sur-Rhône since 2003 and underscores Axplora’s unwavering commitment to regulatory rigor and operational reliability.

“This achievement is the result of our team’s quality, safety, and operational excellence mindset, all delivered with reliability, speed, and efficiency,” said Daniel Lasanow, Site Director. “We are proud to provide a trusted, fully compliant environment that supports our customers’ API development from early-phase projects through to commercial supply.”

With more than 30 clinical and commercial small molecules, the Chasse-sur-Rhône site plays a central role in Axplora’s integrated European CDMO network, which includes five sites with a 100% regulatory inspection success rate. Together, these facilities deliver capabilities for custom development and manufacturing of APIs and intermediates. They also ensure flexibility, scalability, and robust supply for pharmaceutical innovators worldwide, from small-scale to large-scale quantities, throughout the entire product lifecycle.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters